Thank you, Russell, and good morning, everyone. This quarter we once again grew organic sales in each of our two divisions. We increased our gross profit margins, we reduced the SG&A expense as a percent of sales and we grew our bottom line nicely. Each of our two divisions performed very well. IDS grew segment profit by 7.4%, while WPS grew segment profit by 38.4%. Putting it all together, we reported second quarter GAAP EPS of $0.76, compared to $0.65 in the second quarter of last year, an increase of 16.9%. And non-GAAP EPS, which is calculated as our GAAP EPS less the after-tax impact of amortization expense was $0.81 this quarter, compared to $0.70 in the second quarter of last year. So, the key financial takeaways are another quarter of healthy organic sales growth, nicely improved EPS, organic sales, and segment profit growth in each of our two divisions and significantly improved operating cash flow and free cash flow, all of which helped us overcome the year-over-year appreciation of the U.S. dollar and deliver another very respectable quarter. Let's move to our sales trends on Slide number 4. Organic sales grew 6.3% this quarter, but with the stronger U.S. dollar foreign currency translation reduced sales by 3.7% thus bringing total sales growth to 2.6%. The impact of foreign currency reduced IDS sales by 3%, and reduced WPS sales by 6.2%. The reason for the outsized foreign currency impact on WPS is because approximately half of WPS sales are in Western Europe and another 20% of WPS sales are in Australia. Even with this significant foreign currency challenge, our WPS business still performed extremely well this quarter. On Slide number 5, you can see our gross profit margin trending. Our gross profit margin increased 100 basis points to 48%, compared to 47% in the second quarter of last year. We were able to offset the majority of our input cost increases through efficiency gains and pricing actions. And as Russell mentioned, inflation is not gone and we're still experiencing some legs between input cost increases and price increases. Because of this, we expect to continue to see a bit of choppiness in our gross profit margins over the next several quarters. On Slide number 6, you'll find our SG&A expense trending. SG&A was 92.3 million this quarter, compared to 92.5 million in the second quarter of last year. As a percent of sales, SG&A was 28.3%, compared to 29.1% in the second quarter of last year. And if you exclude amortization expense, then SG&A would have declined from 27.9% of sales in Q2 of last year to 27.3% of sales this quarter. In addition to our continual focus on becoming a more efficient organization SG&A expense also benefited from reduced equity based compensation and foreign currency translation. Slide number 7 is the trending of our investments in research and development. This quarter, we invested 15.4 million in R&D, which equates to about 4.7% of sales. We remain committed to new product development as we have opportunities across our businesses, including the development of our newest lines of printers. On Slide number 8, you can see that pretax earnings increased 15.4% on a GAAP basis. If you exclude amortization expense from both the current year and the prior year, then our non-GAAP pretax earnings would have increased 13.1% increasing from 45.8 million in Q2 of last year to 51.8 million this quarter. Slide number 9 illustrates the trending of earnings and EPS on an after tax basis. When you look at these charts, you can see the general trend of up and to the right. Fiscal 2021 was a record EPS year at [2.47] [ph]. We then followed this up with another record year in fiscal 2022 of $2.90, and so far this year EPS is up another 17.4%. On Slide number 10, you'll find a summary of our cash generation. Operating cash flow increased substantially this quarter jumping from a cash outflow of 3.2 million last year to a cash inflow of over 29.4 million this quarter a year-over-year increase of 32.6 million. Timing of our annual incentive based compensation payments factored heavily into this significant year-over-year improvement. Last year, we paid our annual bonuses in the second quarter, whereas this year, they were paid in the first quarter. If you look at the first six months of this year, the timing of incentive based comp payments had no year-over-year comparability impact. Year to date, operating cash flow was up a full 135% to 57.4 million and we expect cash flow to further strengthen in the second half of the year. Now, if you'll turn to Slide number 11, you can see the impact that Brady historically strong cash generation has had on our balance sheet. We are currently in a net cash position of $30.9 million. Our approach to capital allocation is to first and foremost use our cash to fully fund organic sales and efficiency opportunities. This includes investing in new product development, sales generating resources, capability enhancing capital expenditures, and automation focused CapEx. Despite the economic uncertainty, we will continue to deploy capital to drive productivity and sales growth, especially in our businesses where we expect enhanced growth from secular tailwinds. And second, we focus on consistently increasing our dividends. We've increased our dividend every single year since going public. After fully funding organic investments and dividends, we then deploy our cash in a disciplined manner for either acquisitions where we have clear synergistic opportunities or for buybacks in an opportunistic manner when we see a disconnect between intrinsic value and Brady's trading price. Our enviable balance sheet positions us well to execute additional value enhancing activities, including investing in R&D and other organic sales generating activities, completing acquisitions if the price is right, and the synergies are clear, and returning funds to our shareholders. As we look to the future, we're confident that our strong balance sheet and our positive momentum set us up for further success. This brings us to our updated fiscal 2023 guidance, which is articulated on Slide number 12 of the deck. We're raising the low-end of our previously established full-year fiscal 2023 EPS guidance range of $3.30 per share to $3.60 per share to our new range of $3.40 per share to $3.60 per share on a non-GAAP basis. And we're increasing our GAAP guidance range from the previously established range of $3.13 per share to $3.43 per share to our new range of $3.23 per share to $3.43 per share. Our outlook is based on exchange rates as of January 31, and continued economic expansion. Although we're certainly concerned about the stability of the global economy, we're still experiencing nice organic sales growth in most geographies outside of China. As such, we expect full-year organic sales growth to be in the mid-single-digit percentages for the year ending July 31, 2023. Other elements of our guidance include an income tax rate of approximately 21%, depreciation and amortization expense of approximately $32 million to $34 million, and capital expenditures of approximately $22 million. We’ve reduced our CapEx guidance as a result of delays in the start of certain facility projects. We had originally anticipated starting these projects earlier in fiscal 2023 and will now be starting these projects towards the end of this fiscal year. As for capital allocation, we don't foresee any major changes in our strategy. We'll keep investing in our organic business. We just announced another quarterly dividend and will be opportunistic with buybacks, while looking for acquisitions where the price is right and the strategic fit is clear. We have a strong balance sheet and we'll use it as a tool to drive long-term shareholder value. Potential risks to this guidance, among others, includes further strengthening of the U.S. dollar, inflationary pressures that we can't offset in a timely enough manner through price increases, or an overall slowdown in economic activity. I'll now turn the call back to Russell to cover our divisional results and provide some closing thoughts before Q&A. Russell?